These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

746 related articles for article (PubMed ID: 33193102)

  • 21. Modulation of Autoimmune T-Cell Memory by Stem Cell Educator Therapy: Phase 1/2 Clinical Trial.
    Delgado E; Perez-Basterrechea M; Suarez-Alvarez B; Zhou H; Revuelta EM; Garcia-Gala JM; Perez S; Alvarez-Viejo M; Menendez E; Lopez-Larrea C; Tang R; Zhu Z; Hu W; Moss T; Guindi E; Otero J; Zhao Y
    EBioMedicine; 2015 Dec; 2(12):2024-36. PubMed ID: 26844283
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hyaluronan deposition in islets may precede and direct the location of islet immune-cell infiltrates.
    Bogdani M; Speake C; Dufort MJ; Johnson PY; Larmore MJ; Day AJ; Wight TN; Lernmark Å; Greenbaum CJ
    Diabetologia; 2020 Mar; 63(3):549-560. PubMed ID: 31907557
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Partners in Crime: Beta-Cells and Autoimmune Responses Complicit in Type 1 Diabetes Pathogenesis.
    Toren E; Burnette KS; Banerjee RR; Hunter CS; Tse HM
    Front Immunol; 2021; 12():756548. PubMed ID: 34691077
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo islet protection by a nuclear import inhibitor in a mouse model of type 1 diabetes.
    Moore DJ; Zienkiewicz J; Kendall PL; Liu D; Liu X; Veach RA; Collins RD; Hawiger J
    PLoS One; 2010 Oct; 5(10):e13235. PubMed ID: 20949090
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enterovirus infection, CXC chemokine ligand 10 (CXCL10), and CXCR3 circuit: a mechanism of accelerated beta-cell failure in fulminant type 1 diabetes.
    Tanaka S; Nishida Y; Aida K; Maruyama T; Shimada A; Suzuki M; Shimura H; Takizawa S; Takahashi M; Akiyama D; Arai-Yamashita S; Furuya F; Kawaguchi A; Kaneshige M; Katoh R; Endo T; Kobayashi T
    Diabetes; 2009 Oct; 58(10):2285-91. PubMed ID: 19641142
    [TBL] [Abstract][Full Text] [Related]  

  • 26. T-cell assays to determine disease activity and clinical efficacy of immune therapy in type 1 diabetes.
    van de Linde P; Roep BO
    Am J Ther; 2005; 12(6):573-9. PubMed ID: 16280651
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autoimmune disorders in diabetes.
    Boitard C; Debray-Sachs M; Bach JF
    Adv Nephrol Necker Hosp; 1986; 15():281-305. PubMed ID: 3082114
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dextran Sulfate Protects Pancreatic β-Cells, Reduces Autoimmunity, and Ameliorates Type 1 Diabetes.
    Lu G; Rausell-Palamos F; Zhang J; Zheng Z; Zhang T; Valle S; Rosselot C; Berrouet C; Conde P; Spindler MP; Graham JG; Homann D; Garcia-Ocaña A
    Diabetes; 2020 Aug; 69(8):1692-1707. PubMed ID: 32381645
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of reactive oxygen species and proinflammatory cytokines in type 1 diabetes pathogenesis.
    Padgett LE; Broniowska KA; Hansen PA; Corbett JA; Tse HM
    Ann N Y Acad Sci; 2013 Apr; 1281(1):16-35. PubMed ID: 23323860
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The case for an autoimmune aetiology of type 1 diabetes.
    Mannering SI; Pathiraja V; Kay TW
    Clin Exp Immunol; 2016 Jan; 183(1):8-15. PubMed ID: 26313217
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunobiology of beta-cell destruction.
    La Torre D
    Adv Exp Med Biol; 2012; 771():194-218. PubMed ID: 23393680
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autoimmunity triggers in the NOD mouse: a role for natural auto-antibody reactivities in type 1 diabetes.
    Côrte-Real J; Duarte N; Tavares L; Penha-Gonçalves C
    Ann N Y Acad Sci; 2009 Sep; 1173():442-8. PubMed ID: 19758184
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transgenic expression of murine chemokine decoy receptor D6 by islets reveals the role of inflammatory CC chemokines in the development of autoimmune diabetes in NOD mice.
    Lin GJ; Huang SH; Chen YW; Hueng DY; Chia WT; Chien MW; Yen BL; Sytwu HK
    Diabetologia; 2011 Jul; 54(7):1777-87. PubMed ID: 21544515
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunomodulation and regeneration of islet Beta cells by cytokines in autoimmune type 1 diabetes.
    Singh B; Nikoopour E; Huszarik K; Elliott JF; Jevnikar AM
    J Interferon Cytokine Res; 2011 Oct; 31(10):711-9. PubMed ID: 21851268
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasmacytoid dendritic cells are proportionally expanded at diagnosis of type 1 diabetes and enhance islet autoantigen presentation to T-cells through immune complex capture.
    Allen JS; Pang K; Skowera A; Ellis R; Rackham C; Lozanoska-Ochser B; Tree T; Leslie RD; Tremble JM; Dayan CM; Peakman M
    Diabetes; 2009 Jan; 58(1):138-45. PubMed ID: 18835928
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The human pancreatic islet transcriptome: expression of candidate genes for type 1 diabetes and the impact of pro-inflammatory cytokines.
    Eizirik DL; Sammeth M; Bouckenooghe T; Bottu G; Sisino G; Igoillo-Esteve M; Ortis F; Santin I; Colli ML; Barthson J; Bouwens L; Hughes L; Gregory L; Lunter G; Marselli L; Marchetti P; McCarthy MI; Cnop M
    PLoS Genet; 2012; 8(3):e1002552. PubMed ID: 22412385
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The chemokine binding protein M3 prevents diabetes induced by multiple low doses of streptozotocin.
    Martin AP; Alexander-Brett JM; Canasto-Chibuque C; Garin A; Bromberg JS; Fremont DH; Lira SA
    J Immunol; 2007 Apr; 178(7):4623-31. PubMed ID: 17372021
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New Insights into Immunotherapy Strategies for Treating Autoimmune Diabetes.
    Cabello-Olmo M; Araña M; Radichev I; Smith P; Huarte E; Barajas M
    Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31561568
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Autoimmune mechanisms in type 1 diabetes.
    Knip M; Siljander H
    Autoimmun Rev; 2008 Jul; 7(7):550-7. PubMed ID: 18625444
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Islet expression of M3 uncovers a key role for chemokines in the development and recruitment of diabetogenic cells in NOD mice.
    Martin AP; Grisotto MG; Canasto-Chibuque C; Kunkel SL; Bromberg JS; Furtado GC; Lira SA
    Diabetes; 2008 Feb; 57(2):387-94. PubMed ID: 18003753
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.